Editorial
doi: 10.1056/NEJMe058052.
Epub 2005 Mar 8.
Low-density lipoprotein cholesterol in patients with stable coronary heart disease--is it time to shift our goals?
- PMID: 15755764
- DOI: 10.1056/NEJMe058052
Item in Clipboard
Editorial
Low-density lipoprotein cholesterol in patients with stable coronary heart disease--is it time to shift our goals?
N Engl J Med.
.
No abstract available
Comment in
-
Intensive lipid lowering with atorvastatin in coronary disease.N Engl J Med. 2005 Jul 7;353(1):93-6; author reply 93-6. N Engl J Med. 2005. PMID: 16003832 No abstract available.
-
Statin therapy after stroke or transient ischemic attack.N Engl J Med. 2006 Nov 30;355(22):2369-70; author reply 2370-1. N Engl J Med. 2006. PMID: 17139772 No abstract available.
Comment on
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.N Engl J Med. 2005 Apr 7;352(14):1425-35. doi: 10.1056/NEJMoa050461. Epub 2005 Mar 8. N Engl J Med. 2005. PMID: 15755765 Clinical Trial.
Similar articles
-
Intensive lipid lowering with atorvastatin in coronary disease.N Engl J Med. 2005 Jul 7;353(1):93-6; author reply 93-6. N Engl J Med. 2005. PMID: 16003831 No abstract available.
-
Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.Curr Atheroscler Rep. 2006 Jan;8(1):7-8. Curr Atheroscler Rep. 2006. PMID: 16455005 No abstract available.
-
Intensive lipid lowering with atorvastatin in coronary disease.N Engl J Med. 2005 Jul 7;353(1):93-6; author reply 93-6. doi: 10.1056/NEJM200507073530117. N Engl J Med. 2005. PMID: 16000362 No abstract available.
-
Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).Am J Cardiol. 2010 Jan 1;105(1):69-76. doi: 10.1016/j.amjcard.2009.08.651. Am J Cardiol. 2010. PMID: 20102893 Review.
-
[LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].MMW Fortschr Med. 2003 Dec 11;145(50):46-9. MMW Fortschr Med. 2003. PMID: 14963971 Review. German.
Cited by
-
Estimates of commercial population at high risk for cardiovascular events: impact of aggressive cholesterol reduction.Am Health Drug Benefits. 2009 Sep;2(6):224-32. Am Health Drug Benefits. 2009. PMID: 25126293 Free PMC article.
-
Differential effect of membrane cholesterol removal on mu- and delta-opioid receptors: a parallel comparison of acute and chronic signaling to adenylyl cyclase.J Biol Chem. 2009 Aug 14;284(33):22108-22122. doi: 10.1074/jbc.M109.030411. Epub 2009 Jun 11. J Biol Chem. 2009. PMID: 19520863 Free PMC article.
-
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins.Cardiovasc Diabetol. 2006 Sep 26;5:20. doi: 10.1186/1475-2840-5-20. Cardiovasc Diabetol. 2006. PMID: 17002798 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
